Alpha-Synuclein Structure and Parkinson’s Disease – Lessons and Emerging Principles

Molecular Neurodegeneration - United Kingdom
doi 10.1186/s13024-019-0329-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson’s Disease

PLoS ONE
Multidisciplinary
2016English

The Complex Relationships Between Microglia, Alpha-Synuclein, and LRRK2 in Parkinson’s Disease

Neuroscience
Neuroscience
2015English

Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2018English

Clearing Extracellular Alpha-Synuclein From Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease

Brain Sciences
Neuroscience
2018English

Multiscale Investigation of Monomeric Alpha-Synuclein Structure and Aggregation

Biophysical Journal
Biophysics
2019English

Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease

Movement Disorders
Neurology
2014English

Α-Synuclein: A Therapeutic Target for Parkinson’s Disease?

Pharmacological Research
Pharmacology
2008English

Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on Α-Synuclein

Neuron
Neuroscience
2015English

Α-Synuclein and Anti-Α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy